Inflammation in Brain Linked to Schizophrenia
the Psychiatry Advisor take:
Inflammation in the brain may be at the root of schizophrenia as new research indicates that immune cells are more active in people who have the disease and those at risk for it.
Peter Bloomfield, MS, of the Medical Research Council Clinical Sciences Centre at Imperial College London, England, and colleagues used positron emission tomography scans to measure immune cell activity in the brain. They took scans of 56 people — those with schizophrenia, those at risk of the disease, and those with no symptoms or risk.
Activity of microglia, a type of cells responsible for immune defense, in the brain increased as symptoms of schizophrenia got more severe, the researchers reported in the American Journal of Psychiatry. In addition, people diagnosed with schizophrenia had high microglia activity in their brain. And patients with subclinical symptoms of schizophrenia who are at very high risk of psychosis also saw elevated activity.
The researchers concluded that their findings indicate that neuroinflammation is linked to the risk of psychosis and related disorders, as well as the expression of subclinical symptoms.
“Our findings are particularly exciting because it was previously unknown whether these cells become active before or after onset of the disease,” Bloomfield said in a statement. “Now we have shown this early involvement, mechanisms of the disease and new medications can hopefully be uncovered.”
Discovery could lead to development of drugs targeting neuroinflammation.
A study published today in the American Journal of Psychiatry is the first to find that immune cells are more active in the brains of people at risk of schizophrenia as well as those already diagnosed with the disease.
The finding could completely change our current understanding of schizophrenia, raising the possibility that testing people most at risk of the disorder ahead of time could allow them to be treated early enough to avoid its most severe symptoms.
Researchers at the Medical Research Council's (MRC) Clinical Sciences Centre, based at Imperial College London, in collaboration with colleagues at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London, used positron emission tomography (PET) scans to measure levels of activity of immune cells in the brain.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- FOSTA-SESTA Threatens Sex Worker Livelihoods: What Mental Health Providers Should Know
- Strong Social Networks May Mitigate the Effects of Childhood Adversity
- Sodium Valproate May Lower Amygdala Volume in Pediatric Bipolar Disorder
- False Positives in Mood Disorders Questionnaire Screening for Bipolar Disorder
- Suicidal Behavior More Likely in Depression, Bipolar Disorder With Mixed Features
- Medical Clearance of Psych Patients in the ED: Consensus Recommendations
- From Abused Child to Serial Killer: Investigating Nature vs Nurture in Methods of Murder
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Dialectical Behavior Therapy Effective in Reducing Suicide Attempts, Self-Harm in Adolescents
- Novel Parent-Child Interaction Therapy Targets Preschool-Aged Depression
- Challenges Psychiatrists Face in Treating Patients with Bipolar Disorder
- Parent-Child Interaction Therapy May Improve Depression and Emotional Function
- Identifying Problems of Functioning in Schizophrenia Informs Approaches to Intervention
- Visual Hallucinations in Dementia and Parkinson Disease: Assessment of Patient, Caregiver Experiences
- FDA Outlines Plan for Increasing Nonprescription Drug Availability